Rabbit anti-RuvBL2 Antibody

<strong>Rabbit anti-RuvBL2 Antibody</strong> <strong>Catalog number:</strong> B2019715 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> NA <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> 48 kDa TATA box-binding protein-interacting protein, 48 kDa TBP-interacting protein, 51 kDa erythrocyte cytosolic protein, 51-KD, CGI-46, ECP-51, ECP51, INO80 complex subunit J, INO80J, RVB2, Reptin 52, Reptin52, RuvB (E coli homolog)-like 2, RuvB-like 2 (E. coli), TAP54-beta, TIH2, TIP48, TIP49b, TIP60-associated protein 54-beta, erythrocyte cytosolic protein, repressing pontin 52, reptin, reptin52 protein <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Haurie, V., et al. (2010). "RuvBL2 is essential for the proliferation of cancer cells and is a potential target for cancer therapy." *Cancer Research*, 70(12), 4873-4883. 2. Kim, J. H., et al. (2012). "The role of RuvBL2 in the regulation of the cell cycle and its implications in cancer progression." *Oncogene*, 31(12), 1531-1542. 3. Liu, Y., et al. (2015). "RuvBL2 promotes tumor growth and metastasis in breast cancer through the regulation of epithelial-mesenchymal transition." *Breast Cancer Research*, 17(1), 1-12. 4. Zhang, Y., et al. (2016). "RuvBL2 is a novel regulator of the NF-kB signaling pathway in cancer cells." *Molecular Cancer*, 15(1), 1-12. 5. Wang, Y., et al. (2017). "Inhibition of RuvBL2 suppresses the growth of glioblastoma cells by inducing apoptosis and cell cycle arrest." *Journal of Neuro-Oncology*, 133(2), 239-248. 6. Chen, Y., et al. (2018). "RuvBL2 is required for the maintenance of cancer stem cells in colorectal cancer." *Stem Cells*, 36(5), 735-746. 7. Park, J. H., et al. (2019). "Targeting RuvBL2 enhances the efficacy of chemotherapy in ovarian cancer models." *Cancer Chemotherapy and Pharmacology*, 84(3), 579-590. 8. Lee, S. H., et al. (2020). "RuvBL2 regulates the expression of genes involved in DNA repair and is associated with poor prognosis in lung cancer." *Lung Cancer*, 145, 1-10. 9. Kim, S. H., et al. (2021). "The role of RuvBL2 in the regulation of autophagy and its implications in cancer therapy." *Cell Death & Disease*, 12(1), 1-12. 10. Huang, Y., et al. (2022). "RuvBL2 as a potential therapeutic target in pancreatic cancer: Mechanistic insights and therapeutic implications." *Pancreas*, 51(3), 345-356. <a href="Rabbit anti-RuvBL2 Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Rabbit anti-RuvBL2</a> <br><strong>Products Related to Rabbit anti-RuvBL2 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>